TEMIXYS Trademark

Trademark Overview


On Thursday, February 1, 2018, a trademark application was filed for TEMIXYS with the United States Patent and Trademark Office. The USPTO has given the TEMIXYS trademark a serial number of 79229584. The federal status of this trademark filing is REGISTERED as of Tuesday, January 15, 2019. This trademark is owned by CELLTRION, INC.. The TEMIXYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparation...
temixys

General Information


Serial Number79229584
Word MarkTEMIXYS
Filing DateThursday, February 1, 2018
Status700 - REGISTERED
Status DateTuesday, January 15, 2019
Registration Number5652077
Registration DateTuesday, January 15, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, January 15, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 25, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 4, 2019FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 4, 2019FINAL DISPOSITION PROCESSED
Monday, April 15, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Friday, October 26, 2018NOTIFICATION PROCESSED BY IB
Wednesday, October 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 17, 2018ASSIGNED TO LIE
Wednesday, September 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 30, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, August 30, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 30, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, August 30, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 22, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 22, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 8, 2018REFUSAL PROCESSED BY IB
Monday, May 21, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 21, 2018REFUSAL PROCESSED BY MPU
Wednesday, May 16, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 15, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Tuesday, April 10, 2018APPLICATION FILING RECEIPT MAILED
Friday, April 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB